approved a Distribution Agreement with Aspeya India Private Limited on 15th May 2026 for the distribution and re-sale of Nicotine Replacement Therapy products through domestic approved channels of trade. The initial term of the agreement is three years, subject to customary warranties and indemnities. Aspeya India, a related party entity linked to foreign promoter Philip Morris Global Brands Inc., USA, reported revenue from operations of Rs. 795.06 lakhs and profit after tax of Rs. 19.32 lakhs for the year ended 31st March 2025. The agreement is intended to leverage Godfrey Phillips India's distribution network to add to its top-line and bottom-line. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.